tiprankstipranks
Trending News
More News >
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
US Market

MoonLake Immunotherapeutics (MLTX) Ownership - Who Owns MoonLake Immunotherapeutics?

Compare
326 Followers

MoonLake Immunotherapeutics (MLTX) Ownership Overview

27.07%17.95%0.28%0.69%54.01%
27.07% Insiders
0.28% Other Institutional Investors
0.69% ETFs
54.01% Public Companies and
Individual Investors
The ownership structure of MoonLake Immunotherapeutics (MLTX) stock is a mix of institutional, retail, and individual investors. Approximately 18.92% of the company’s stock is owned by Institutional Investors, 27.07% is owned by Insiders, and 54.01% is owned by Public Companies and Individual Investors.
The ownership structure of MoonLake Immunotherapeutics (MLTX) stock is a mix of institutional, retail, and individual investors. Approximately 18.23% of the company’s stock is owned by Institutional Investors, 27.07% is owned by Insiders, and 0.69% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 08, 2024
xxxxxxxxxxxxx
$9186120
Oct 08, 2024
xxxxxxxxxxxxx
$100000000

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2024
xxxxxxxxxxxxx
$1299600
Dec 31, 2024
xxxxxxxxxxxxx
$15894920

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,494,151Insider14.17%312,329,932
3,078,577Insider4.86%113,199,276
3,009,940Insider4.76%110,675,494
1,564,479Institution2.47%57,525,893
1,287,768Insider2.03%47,351,229
1,200,858Institution1.90%44,155,549
1,184,000Institution1.87%43,535,680
912,310Institution1.44%33,545,639
780,388Institution1.23%28,694,867
704,819Institution1.11%25,916,195

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,564,479Institution2.47%57,525,893
1,200,858Institution1.90%44,155,549
1,184,000Institution1.87%43,535,680
912,310Institution1.44%33,545,639
780,388Institution1.23%28,694,867
704,819Institution1.11%25,916,195
667,176Institution1.05%24,532,062
581,762Institution0.92%21,391,389
548,604Institution0.87%20,172,169
364,970Institution0.58%13,419,947

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
70,568Institution0.11%2,946,920
47,301Institution0.07%1,739,258
46,936Institution0.07%1,960,047
41,336Institution0.07%1,477,762
25,442Institution0.04%935,502
25,406Institution0.04%1,534,911
23,038Institution0.04%847,107
19,476Institution0.03%813,318
15,825Institution0.03%660,852
14,505Institution0.02%518,554

FAQ

Who Owns MoonLake Immunotherapeutics (MLTX)?
According to the latest TipRanks data, approximately 0.28% of the company's stock is held by institutional investors, 27.07% is held by insiders, and 54.01% is held by retail investors.
    What percentage of MoonLake Immunotherapeutics (MLTX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.28% of MoonLake Immunotherapeutics (MLTX) stock is held by institutional investors.
      What percentage of MoonLake Immunotherapeutics (MLTX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 54.01% of MoonLake Immunotherapeutics (MLTX) stock is held by retail investors.
        Who owns the most shares of MoonLake Immunotherapeutics (MLTX)?
        Chen Bihua owns the most shares of MoonLake Immunotherapeutics (MLTX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis